|
![]() |
|||
|
||||
OverviewIn this issue, guest editors bring their considerable expertise to this important topic. Provides in-depth reviews on the latest updates in the field, providing actionable insights for clinical practice. Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create these timely topic-based reviews. Full Product DetailsAuthor: Markham C. Luke (Food and Drug Administration)Publisher: Elsevier - Health Sciences Division Imprint: Elsevier - Health Sciences Division Weight: 0.410kg ISBN: 9780323849692ISBN 10: 0323849695 Pages: 240 Publication Date: 27 June 2022 Audience: Professional and scholarly , Professional & Vocational Format: Hardback Publisher's Status: Active Availability: Manufactured on demand ![]() We will order this item for you from a manufactured on demand supplier. Table of ContentsThe History of Dermatology and Dermatologists at the US Food and Drug Administration The Food and Drug Administration's Role in Dermatologic Drug Development Postmarket Assessment for Drugs and Biologics Used in Dermatology and Cutaneous Adverse Drug Reactions How Does the Food and Drug Administration Approve Topical Generic Drugs Applied to the Skin? Dermatology Drugs for Children-U.S. Food and Drug Administration Perspective Regulation of Medical Devices for Dermatology Regulation of Cosmetics in the United States Cutaneous Pharmacokinetic Approaches to Compare Bioavailability and/or Bioequivalence for Topical Drug Products Measuring What Matters to Patients in Dermatology Drug Development: A Regulatory PerspectiveReviewsAuthor InformationTab Content 6Author Website:Countries AvailableAll regions |